Garrett Vygantas

Garrett is a frequent lecturer at UCSF's Center for BioEntrepreneurship and has advised in the formation of numerous biotech start-ups. Garrett completed his Transitional Residency at the University of Pennsylvania and holds MD and MBA degrees from Georgetown University as well as a BS in biochemistry from Boston College.

Garrett joined OSF Ventures, part of the 14-hospital integrated delivery system called OSF Healthcare, in 2017 as a Managing Director. He is focused on investing in healthcare companies seeking to make an impact in the provider'patient ecosystem. Garrett currently serves on the board of Gauss Surgical, Pieces Technologies, and Level Ex. Previously, Garrett was a Partner with Jump Capital where he led investments in digital health for Chicago-based Jump Capital. 

​

Garrett 'was 'Founding CEO of NewBridge Pharma, a Dubai-based specialty pharmaceutical company commercializing innovative therapies', medical devices, and molecular diagnostics' 'across' 'the emerging markets of the Middle East, Africa, Turkey, and Caspian regions (AfMET)'. During his tenure, the company grew to 100+ employees, raised $65 million in financing over 3 rounds, and created $470 million in nominal value. 

​

Garrett was also an 'Entrepreneur-In-Residence 'and Director with the Burrill Venture Group. He joined in 2006 'where he source'd, evaluate'd, and structure'd' new investment opportunities across biotech, pharma, life science, 'and healthcare spectrum's. 

​

Earlier in his career, Garrett founded Ceratotech and co-founded Mitre Medical. At Genentech, he was on the commercialization and launch team of Lucentis for the treatment of age-related macular degeneration. Garrett previously worked with the Health Care Investment Banking group at Cowen and in business development at the biotech company EntreMed.

Garrett is a member of Kauffman Fellows Class 13, and performed his fellowship under mentor Steve Burrill at Burrill & Company. He later served as mentor to Peter Johnson, Class 20.